Aktie A0M4EC GUANGXI WUZHOU ZHONGHENG GROUP CO.,LTD
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen Guangxi Wuzhou Zhongheng Group Co.,Ltd

Aktien

A0M4EC

CNE0000015F9

600252

Schlusskurs Shanghai S.E.
Andere Börsenplätze
 00:00:00 15.07.2024 		% 5 Tage % 1. Jan.
2.21 CNY -0.90% Intraday Chart für Guangxi Wuzhou Zhongheng Group Co.,Ltd +1.38% -11.95%
05.06. Zhongheng Group erhält Arzneimittelzulassungszertifikat für neues Atemwegsmedikament MT
20.05. Guangxi Wuzhou Zhongheng Group Co.,Ltd kündigt eine Erhöhung des Aktienrückkaufs an. CI

Andere Sprachen

Suchen
Ergebnisse ansehen
Schalten Sie alle Nachrichten frei: Seien Sie als Erster informiert und reagieren Sie vor den Märkten!
100% kostenlose Registrierung
Tranche Update on Guangxi Wuzhou Zhongheng Group Co.,Ltd's Equity Buyback Plan announced on April 17, 2024.
Zhongheng Group Secures Drug Registration Certificate for New Respiratory Drug
Guangxi Wuzhou Zhongheng Group Co.,Ltd announces an Increase in Equity Buyback.
Guangxi Wuzhou Zhongheng Group Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024
Guangxi Wuzhou Zhongheng Group Co.,Ltd commences an Equity Buyback for CNY 200 million worth of its shares, under the authorization approved on March 28, 2024.
Guangxi Honggui Capital Operation Group Co.,Ltd. agreed to acquire 18% stake in Guangxi United Asset Management Co., Ltd from Guangxi Wuzhou Zhongheng Group Co.,Ltd for approximately CNY 190 million.
Guangxi Wuzhou Zhongheng Group Co.,Ltd Reports Earnings Results for the Full Year Ended December 31, 2023
Lummy Pharma Gets Nod to Raise Dosage of Gastric Drug
Wuzhou Zhongheng’s Drug For Preventing Chemotherapy-Related Nausea Passes Consistency Test
Sealand Securities Co., Ltd. announced that it has received CNY 3.192189985 billion in funding from a group of investors
Guangxi Wuzhou Zhongheng Group Co.,Ltd Reports Earnings Results for the Nine Months Ended September 30, 2023
Guangxi Wuzhou Zhongheng Group Co.,Ltd(XSSC:600252) added to S&P Global BMI Index
Guangxi Wuzhou Zhongheng Group Co.,Ltd(XSSC:600252) added to FTSE All-World Index
Wuzhou Zhongheng Gets Nod to Trial Ovarian Cancer Drug
Guangxi Wuzhou Zhongheng Group Co.,Ltd Reports Earnings Results for the Half Year Ended June 30, 2023
Guangxi Wuzhou Zhongheng Receives 42 Million Yuan in Government Subsidy
Guangxi Wuzhou Zhongheng Group Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2023
Guangxi Wuzhou Zhongheng Group Co.,Ltd Reports Earnings Results for the Full Year Ended December 31, 2022
Restrictions on Guangxi Wuzhou Zhongheng Drugs in 2022 Chinese Drug Catalogue Amended
Guangxi Wuzhou Zhongheng Group Co.,Ltd Reports Earnings Results for the Nine Months Ended September 30, 2022
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. A0M4EC Aktie
  4. Nachrichten Guangxi Wuzhou Zhongheng Group Co.,Ltd
  5. Andere Sprachen